With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...
20hon MSN
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
The approval of neffy marks the first major advancement in epinephrine delivery for patients over four years of age in more ...
Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months.
3don MSN
This is just the new way of consuming nicotine,” a vape shop owner in West Campus says of continuing to sell flavored vapes.
A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s.
1d
Midland Daily News on MSNHow the FDA opens the door to risky chemicals in America’s food supplyThe FDA's limited control over food additives, compared to Europe, raises health concerns as many chemicals in U.S. foods are ...
In the SWIFT and ANCHOR trials, depemokimab demonstrated statistically significant reductions in nasal polyp size, ...
An Australian man in his forties has become the first person in the world to leave hospital with an artificial heart made of ...
MacTel is a rare, progressive eye disease that affects the macula and causes a gradual deterioration in central vision.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results